Recurrent Gastric Cancer Completed Phase 1 Trials for Sargramostim (DB00020)

Also known as: Gastric cancer recurrent / Stomach cancer recurrent / Stomach carcinoma recurrent / Gastric carcinoma recurrent

IndicationStatusPhase
DBCOND0028800 (Recurrent Gastric Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00028496Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerTreatment